Gene · 84061
Papers1,892
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,892
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Spectrum of Primary Hemophagocytic Lymphohistiocytosis-Associated Gene Mutations in Chinese Patients. | MedComm (2020) | 2026 | 42688879 | PubTator, text mining | PubMed |
| The lithium-magnesium-zinc axis under stress: regulation of N-glycosylation-linked proteostasis and Alzheimer's disease. | Inflammopharmacology | 2026 | 42680959 | PubTator, text mining | PubMed |
| Inhibitors of IAP/XIAP enhance activity of sacituzumab govitecan. | J Natl Cancer Inst | 2026 | 42569934 | PubTator, text mining | PubMed |
| Biomarkers for assessing magnesium status. | Adv Clin Chem | 2026 | 42336500 | PubTator, text mining | PubMed |
| The SMAC-mimetic xevinapant differentially enhances cisplatin and immune checkpoint blockade efficacy in high-risk HPV-positive tumors. | Transl Oncol | 2026 | 42235210 | PubTator, text mining | PubMed |
| Integrative Genomic Analysis Identifies MAGT1 as a Key Regulator of Proliferation and Poor Prognosis in Breast Cancer. | Hum Mutat | 2026 | 42006149 | PubTator, text mining | PubMed |
| Modifier-Sensitive Phenotypic Divergence in XMEN Disease (MAGT1 Deficiency): Neurodegenerative and Immuno-Hematologic Trajectories. | J Clin Med | 2026 | 41899319 | PubTator, text mining | PubMed |
| Risk of Functional Disorders and/or Thyroid Autoimmunity and Its Association with 25OH Vitamin D and Magnesium Levels: A Population-Based Case-Control Study. | Med Sci (Basel) | 2026 | 41892858 | PubTator, text mining | PubMed |
| Second allogeneic stem cell transplantation for XMEN disease. | BMJ Case Rep | 2026 | 41871900 | PubTator, text mining | PubMed |
| Case Report: Novel MAGT1 pathogenic variant with significant atopy, hypogammaglobulinemia and viral skin infections. | Front Immunol | 2026 | 41777878 | PubTator, text mining | PubMed |
| The SLC41 Family of Magnesium Transporters: Molecular Regulators of Magnesium Homeostasis and Their Multifaceted Roles in Human Diseases. | Int J Mol Sci | 2026 | 41751808 | PubTator, text mining | PubMed |
| Central nervous system involvement in pediatric hemophagocytic lymphohistiocytosis: A single-center descriptive study of clinical features, neurodiagnostic findings, and outcomes. | Clin Hematol Int | 2026 | 41726770 | PubTator, text mining | PubMed |
| Identification, structural elucidation and nonclinical characterisation of oxMET1: a further major metabolite of xevinapant? | Xenobiotica | 2026 | 41697154 | PubTator, text mining | PubMed |
| Case Report: A successful case of allogeneic stem cell transplantation for pediatric XMEN characterized by neutropenia. | Front Immunol | 2026 | 41624006 | PubTator, text mining | PubMed |
| [XMEN disease diagnosed following persistent Epstein-Barr virus viremia and recurrent lymphadenopathy]. | Rinsho Ketsueki | 2026 | 41621963 | PubTator, text mining | PubMed |
| Indirect ubiquitination independent of endogenous ubiquitination machinery for targeted protein degradation. | Commun Chem | 2026 | 41611823 | PubTator, text mining | PubMed |
| RSV temporally reprograms apoptosis and pyroptosis to balance immune evasion and replication. | Sci Adv | 2026 | 41576161 | PubTator, text mining | PubMed |
| Novel quinoxaline-based survivin degraders overcome docetaxel-resistance in castration-resistant prostate cancer. | Drug Resist Updat | 2026 | 41539240 | PubTator, text mining | PubMed |
| Survivin recombinant overlapping peptide (ROP) vaccine in advanced solid tumours: a first-in-human, multicentre, open-label, phase 1a dose-escalation study. | EClinicalMedicine | 2026 | 41536940 | PubTator, text mining | PubMed |
| Evolving Neoadjuvant, Adjuvant, and Concurrent Systemic Therapy Strategies in Head and Neck Squamous Carcinoma. | Otolaryngol Clin North Am | 2026 | 41152067 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/84061/papers